Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of apixaban in patients with short bowel syndrome requiring long-term parenteral nutrition
2020-001601-23Phase 2Active
- Sponsor
- UZ Leuven
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of apixaban in short bowel syndrome (SBS) and venous thromboembolism (VTE), sponsored by UZ Leuven. Started May 2020; status: active.
02
Drugs
apixaban
03
Conditions
short bowel syndrome (SBS)venous thromboembolism (VTE)
Beyond the preview
Go deeper on 2020-001601-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001601-23.